scispace - formally typeset
W

William N. Charman

Researcher at Monash University

Publications -  199
Citations -  18654

William N. Charman is an academic researcher from Monash University. The author has contributed to research in topics: Lymphatic system & Bioavailability. The author has an hindex of 65, co-authored 199 publications receiving 17219 citations. Previous affiliations of William N. Charman include Chicago College of Osteopathic Medicine & University of Nebraska Medical Center.

Papers
More filters
Journal ArticleDOI

Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model.

TL;DR: The results were in contrast to the suggested hypothesis since the QT interval was reduced (and not increased) after halofantrine administration to hyperlipidaemic rabbits relative to fasted rabbits, suggesting it is unlikely that lipoprotein‐based uptake of hal ofantrine into the myocardium is a major contributor to the previously observed increase in QT prolongation after post‐prandial administration.
Journal ArticleDOI

Amino acid derivatives of dapsone as water-soluble prodrugs

TL;DR: The alanine, glycine, leucine, lysine, and phenylalanine derivatives of dapsone all exhibited greater aqueous solubility, as their salts, than the parent compound.
Journal ArticleDOI

Orally Active Antimalarials: Hydrolytically Stable Derivatives of 10-Trifluoromethyl Anhydrodihydroartemisinin†

TL;DR: New fluoroart Artemisinin derivatives containing polar or water-soluble functionalities at C-16 (11a-j, 12a-g) were synthesized using the key intermediate 16-bromo-10-trifluoromethyl anhydrodihydroartemisinin 10, and among them, amines 11a-c appeared to be highly in vivo efficient antimalarials on mice infected with Plasmodium berghei.
Journal ArticleDOI

Synthesis, structure-activity relationships and brain uptake of a novel series of benzopyran inhibitors of insulin-regulated aminopeptidase

TL;DR: The present study describes the medicinal chemistry campaign that led to the development of the lead candidate, 3, highlighting the key structural features considered as critical for binding.